• Breast Cancer Antigen CA 15-3
  • Obstetric Panel
  • Ammonia, Serum
  • Candida albicans, Antigen
  • Dopamine D1 receptor (DRD1) Antibody, IgG
  • B and T Cell Gene Rearrangement, Bone Marrow
  • Amino Acids Quantitative by LC-MS/MS, Plasma
  • Septin 9 (SEPT9) Gene Mutation Analysis
  • Thiamylal, Urine
  • Vitamin B6 (Pyridoxal Phosphate)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Interpretation
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.
Loading...